中国网财经2月25日讯(记者 段思琦)2月23日，首都医科大学附属北京天坛医院正式启动阿利妥治疗急性缺血性卒中患者的有效性及安全性研——一项随机对照研究：Aleeto in Acute ISchemic Stroke：A RandomISed ...

The challenges of translating neuroprotective interventions with promising efficacy in animal studies into effective ...

Background: Acute mesenteric ischaemia and duodenal perforation are surgical emergencies with serious consequences. Patients presenting with acute mesenteric ischaemia alone face a high mortality ...

TIA is an acute ischemic event in the brain that typically resolves within two to 15 minutes, often leaving no detectable ...

The following is a summary of “Association between impaired brachial flow-mediated dilation and early neurological ...

The following is a summary of “Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion,” published in the February ...

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...

An update from Diamedica Therapeutics ( ($DMAC) ) is now available. On February 20, 2025, DiaMedica Therapeutics appointed Daniel J. O’Connor to ...

DiaMedica Therapeutics (DMAC) announced the peer-reviewed publication entitled: “Recombinant human tissue kallikrein-1 for treating acute ...

In animal studies of acute stroke, bradykinin B2 receptor expression on brain endothelial cells in the ischemic region increased 36-fold. In this environment, newly generated bradykinin from DM199 ...